Shares of Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $9.8333.
Several research firms have recently weighed in on DHC. Maxim Group lifted their price objective on Diversified Healthcare Trust from $10.00 to $10.50 and gave the company a “buy” rating in a research note on Wednesday, June 3rd. B. Riley Financial boosted their price objective on Diversified Healthcare Trust from $8.50 to $11.00 and gave the company a “buy” rating in a report on Tuesday, June 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research report on Monday, April 20th. Royal Bank Of Canada raised their target price on Diversified Healthcare Trust from $6.00 to $8.00 and gave the company a “sector perform” rating in a research report on Thursday, June 18th. Finally, Wall Street Zen cut shares of Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th.
Check Out Our Latest Report on Diversified Healthcare Trust
Hedge Funds Weigh In On Diversified Healthcare Trust
Diversified Healthcare Trust Stock Up 0.2%
Shares of NASDAQ:DHC opened at $8.93 on Thursday. The stock’s 50-day moving average price is $8.82 and its two-hundred day moving average price is $7.32. The company has a current ratio of 5.36, a quick ratio of 5.36 and a debt-to-equity ratio of 1.48. Diversified Healthcare Trust has a 12-month low of $3.18 and a 12-month high of $9.66. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of -6.71 and a beta of 2.28.
Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) last released its earnings results on Monday, May 4th. The real estate investment trust reported ($0.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.03). The company had revenue of $366.47 million during the quarter, compared to analysts’ expectations of $380.18 million. Diversified Healthcare Trust had a negative net margin of 21.10% and a negative return on equity of 18.75%. Diversified Healthcare Trust has set its FY 2026 guidance at 0.520-0.580 EPS. On average, research analysts forecast that Diversified Healthcare Trust will post 0.6 EPS for the current year.
Diversified Healthcare Trust Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 13th. Shareholders of record on Monday, July 20th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, July 20th. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. Diversified Healthcare Trust’s dividend payout ratio (DPR) is presently -3.01%.
About Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.
The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.
Featured Stories
- Five stocks we like better than Diversified Healthcare Trust
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
